Together with abdominal USG, AFP has been used as a screening method in populations at high risk for HCC development [5–9] as well as for non-biopsy HCC diagnosis [5, 32] and the assessment of treatment responses [33]. The gene discussed is AFP; the disease is hepatocellular carcinoma.